Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplant.
Ramchandren
Radhakrishnan
R
Gladstone
Douglas E
DE
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use; D003453:Cryptococcosis / Q000175:diagnosis* / Q000188:drug therapy; D003454:Cryptococcus / Q000302:isolation & purification*; D003561:Cytarabine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous / Q000009:adverse effects*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000942:Antigens, Bacterial; D000998:Antiviral Agents; D003561:Cytarabine; D005047:Etoposide